Grown Rogue International (GRUSF) Revenue (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Revenue of $9.2 million for Q1 2026, up 28.05% year-over-year from $7.2 million in Q1 2025, and up 100.0% quarter-over-quarter from -$16499.5 billion in Q4 2025.
Grown Rogue International (GRUSF) Revenue (2009 - 2026) Analysis & Trends
Grown Rogue International's Revenue history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Revenue rose 28.05% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $5559521864.0 billion (up 12481651789555.06% YoY), while the FY2025 annual figure was $32.4 million, up 21.81% from the prior year.
- Revenue for Q1 2026 stood at $9.2 million, up from -$16499.5 billion in the prior quarter.
- The five-year high for Revenue was $5559533000.0 billion in Q2 2025, with the low at -$16499.5 billion in Q4 2025.
- The 5-year median for Revenue is $6.7 million (2024), against an average of $370634790.9 billion.
- Peak annual rise in Revenue reached 98520228397318.12% in 2025, while the deepest fall reached 61976161.19% in 2025.
- Grown Rogue International's Revenue stood at $3.7 million in 2022, then fell by 2.54% to $3.6 million in 2023, then soared by 631.77% to $26.6 million in 2024, then sank by 61976161.19% to -$16499.5 billion in 2025, then surged by 100.0% to $9.2 million in 2026.
- Business Quant data shows GRUSF's Revenue at $9.2 million in Q1 2026, -$16499.5 billion in Q4 2025, and $5363.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | 11.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.27 Mn |
| Mar 31, 2026 | 9.16 Mn |
| Dec 31, 2025 | -16,499.45 Bn |
| Sep 30, 2025 | 5,363.49 Bn |
| Jun 30, 2025 | 5,559,533,000.00 Bn |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 5.13 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 6.65 Mn |
| Dec 31, 2023 | 3.64 Mn |
| Oct 31, 2023 | 18.82 Mn |
| Jul 31, 2023 | 12.30 Mn |
| Apr 30, 2023 | 6.00 Mn |
| Jan 31, 2023 | 4.53 Mn |
| Jan 31, 2022 | 3.73 Mn |
| Oct 31, 2021 | 3.76 Mn |
| Jul 31, 2021 | 3.03 Mn |
| Apr 30, 2021 | 1.54 Mn |
| Jan 31, 2021 | 1.05 Mn |